Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Am J Hematol ; 92(1): 88-93, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27779769

ABSTRACT

Anemia is an independent risk factor for adverse patient outcomes. There are no guidelines for management of anemia in patients with congestive heart failure (CHF), despite its high incidence. Four objectives were defined by the International Anemia Management and Clinical Outcomes Expert Panel (AMCO), a multinational group of interdisciplinary experts identified by the Society for the Advancement of Blood Management (SABM) to: determine the prevalence of anemia in outpatients; to determine the prevalence of hospital-acquired anemia; to assess the impact of anemia management on clinical outcomes such as quality of life and functional status; and to provide recommendations for primary care physicians and specialists for the diagnosis, evaluation, and management of anemia in patients with CHF. Anemia and iron deficiency were confirmed to be highly prevalent in patients with CHF. Intravenous iron therapy improves anemia, cardiac function and exercise tolerance, leading to improvement in quality of life. Anemia management has been demonstrated to be cost-effective. Clinical care pathways to manage anemia in patients with CHF are recommended as best practices in order to improve patient outcomes. Am. J. Hematol. 92:88-93, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Anemia, Iron-Deficiency/drug therapy , Heart Failure/drug therapy , Iron Compounds/therapeutic use , Anemia, Iron-Deficiency/blood , Anemia, Iron-Deficiency/epidemiology , Anemia, Iron-Deficiency/etiology , Heart Failure/blood , Heart Failure/complications , Heart Failure/epidemiology , Humans , Injections, Intravenous , Iron Compounds/administration & dosage , Prevalence , Treatment Outcome
2.
Transfusion ; 56(10): 2406-2411, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27546388

ABSTRACT

Despite 20 years of published medical society guidelines for blood transfusion and a pivotal clinical trial in 1999 providing Level 1 evidence that restrictive transfusion practices can be utilized safely, blood transfusions did not begin to decline in the United States until 2010. Widespread adoption of electronic medical records allowed implementation of computerized systems such as clinical decision support (CDS) with best practice alerts to improve blood utilization. We describe our own experience using well-designed and highly targeted CDS to promote restrictive transfusion practices and improve red blood cell utilization, with a 42% reduction in blood transfusions from 2009 through 2015, accompanied by improved clinical outcomes.


Subject(s)
Decision Support Systems, Clinical/trends , Erythrocyte Transfusion/statistics & numerical data , Blood Transfusion/statistics & numerical data , Blood Transfusion/trends , Electronic Health Records , Humans , Practice Patterns, Physicians' , United States
3.
J Hosp Med ; 10(1): 1-7, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25044190

ABSTRACT

BACKGROUND: Best practice alerts (BPAs) provide clinical decision support (CDS) at the point of care to reduce unnecessary blood product transfusions, yet substantial transfusions continue outside of recommended guidelines. OBJECTIVE: To understand why providers order blood transfusions outside of recommended guidelines despite interruptive alerts. DESIGN: Retrospective review. SETTING: Tertiary care hospital. PARTICIPANTS: Inpatient healthcare providers. INTERVENTION: Provider-BPA interaction data were collected from January 2011 to August 2012 from the hospital electronic medical record. MEASUREMENTS: Provider (free-text) responses to blood transfusion BPA prompts were independently reviewed and categorized by 2 licensed physicians, with agreement assessed by χ(2) analysis and kappa scoring. RESULTS: Rationale for overriding blood transfusion BPAs was highly diverse, acute bleeding being the most common (>34%), followed by protocolized behaviors on specialty services (up to 26%), to "symptomatic" anemia (11%-12%). Many providers transfused in anticipation of surgical or procedural intervention (10%-15%) or imminent hospital discharge (2%-5%). Resident physicians represented the majority (55%) of providers interacting with BPAs. CONCLUSION: Providers interacting with BPAs (primarily residents and midlevel providers) often do not have the negotiating power to change ordering behavior. Protocolized behaviors, unlikely to be influenced by BPAs, are among the most commonly cited reasons for transfusing outside of guidelines. Symptomatic anemia is a common, albeit subjective, indication cited for blood transfusion. With a wide swath of individually uncommon rationales for transfusion behavior, secondary use of electronic medical record databases and integrated CDS tools are important to efficiently analyze common practice behaviors.


Subject(s)
Blood Transfusion/standards , Electronic Health Records/standards , Medical Order Entry Systems/standards , Physicians/standards , Practice Guidelines as Topic/standards , Blood Transfusion/economics , Electronic Health Records/economics , Health Personnel/standards , Humans , Medical Order Entry Systems/economics , Retrospective Studies
4.
Ann Thorac Surg ; 51(5): 703-704, 1991 May.
Article in English | MEDLINE | ID: mdl-28327310
SELECTION OF CITATIONS
SEARCH DETAIL
...